MX2011009808A - Agentes de elaboracion de imagen optica. - Google Patents

Agentes de elaboracion de imagen optica.

Info

Publication number
MX2011009808A
MX2011009808A MX2011009808A MX2011009808A MX2011009808A MX 2011009808 A MX2011009808 A MX 2011009808A MX 2011009808 A MX2011009808 A MX 2011009808A MX 2011009808 A MX2011009808 A MX 2011009808A MX 2011009808 A MX2011009808 A MX 2011009808A
Authority
MX
Mexico
Prior art keywords
optical imaging
imaging agents
agents
imaging contrast
kda
Prior art date
Application number
MX2011009808A
Other languages
English (en)
Spanish (es)
Inventor
Randall Lee Carter
Jason William Castle
Kenneth Michael Fish
Anup Sood
Natalie Anne Staples
Brian Dub-Ian Lee
Original Assignee
Gen Electric
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Electric filed Critical Gen Electric
Publication of MX2011009808A publication Critical patent/MX2011009808A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
MX2011009808A 2009-03-19 2010-03-19 Agentes de elaboracion de imagen optica. MX2011009808A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16153509P 2009-03-19 2009-03-19
PCT/EP2010/053619 WO2010106169A1 (en) 2009-03-19 2010-03-19 Optical imaging agents

Publications (1)

Publication Number Publication Date
MX2011009808A true MX2011009808A (es) 2011-09-30

Family

ID=42331047

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011009808A MX2011009808A (es) 2009-03-19 2010-03-19 Agentes de elaboracion de imagen optica.

Country Status (11)

Country Link
US (1) US20120114563A1 (https=)
EP (1) EP2413976A1 (https=)
JP (1) JP2012520856A (https=)
KR (1) KR20110138246A (https=)
CN (1) CN102438659A (https=)
AU (1) AU2010224789A1 (https=)
BR (1) BRPI1009346A2 (https=)
CA (1) CA2755770A1 (https=)
MX (1) MX2011009808A (https=)
RU (1) RU2011138096A (https=)
WO (1) WO2010106169A1 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201015806D0 (en) 2010-09-21 2010-10-27 Ge Healthcare As Vascular imaging agents
US10053447B2 (en) 2010-12-21 2018-08-21 Pierce Biotechnology, Inc Fluorescent compounds
US8889884B1 (en) 2011-07-14 2014-11-18 Pierce Biotechnology, Inc. Phosphine derivatives of fluorescent compounds
MX350082B (es) 2011-07-29 2017-08-24 Avelas Biosciences Inc Moleculas de entrega selectiva y metodos de uso.
US9249307B2 (en) 2011-08-16 2016-02-02 Pierce Biotechnology, Inc. Benzocyanine compounds
GB201116733D0 (en) 2011-09-28 2011-11-09 Ge Healthcare As Peptide margin imaging agents
US9751868B2 (en) 2012-02-28 2017-09-05 Pierce Biotechnology, Inc. Benzocyanine compounds
CN104395306B (zh) 2012-03-02 2019-04-23 皮尔斯生物科技有限公司 作为生物分子的标记染料的吲哚衍生物
WO2014013730A1 (en) * 2012-07-20 2014-01-23 Canon Kabushiki Kaisha Compound and photoacoustic imaging contrast medium containing the compound
JP6288970B2 (ja) * 2012-07-20 2018-03-07 キヤノン株式会社 化合物、および、前記化合物を有する光音響イメージング用造影剤
CN104540819B (zh) 2012-08-28 2019-04-19 皮尔斯生物科技有限公司 苯并吡喃鎓化合物
US20150258217A1 (en) * 2012-10-04 2015-09-17 The General Hospital Corporation Methods of Synthesizing and Using Peg-Like Fluorochromes
WO2014115206A1 (ja) * 2013-01-28 2014-07-31 独立行政法人科学技術振興機構 組織透明化方法、組織透明化試薬及び組織観察方法
AU2014212308B2 (en) * 2013-01-30 2018-08-09 Avelas Biosciences, Inc. Selective delivery molecules and methods of use
FR3001463B1 (fr) * 2013-01-31 2015-02-20 Commissariat Energie Atomique Particules luminescentes de carbone, procede de preparation et utilisation
EP3052136A4 (en) * 2013-10-02 2017-06-21 University of Massachusetts Surface functionalized, host-guest polymer nano-assemblies and methods thereof
US9416276B2 (en) 2013-11-07 2016-08-16 Canon Kabushiki Kaisha Method for producing contrast agent
US10245329B2 (en) 2014-09-08 2019-04-02 Canon Kabushiki Kaisha Composition having dye and conjugate of polyethyleneglycol and additive and contrast agent for photoacoustic imaging having the same
US11027026B2 (en) 2014-10-16 2021-06-08 Canon Kabushiki Kaisha Polymer, and contrast agent for photoacoustic imaging, including the polymer
WO2016063817A1 (en) 2014-10-24 2016-04-28 Canon Kabushiki Kaisha Polymer and contrast agent for photoacoustic imaging including the polymer
JP6700750B2 (ja) 2014-12-09 2020-05-27 キヤノン株式会社 化合物、および、前記化合物を有する光学イメージング用造影剤
HUE051161T2 (hu) * 2014-12-19 2021-03-01 Bracco Imaging Spa Operáció közbeni képalkotás
EP3242690B1 (en) * 2015-01-06 2020-09-16 De Haas, Anthony H. Near-infrared fluorescent surgical dye markers
JP2017002000A (ja) * 2015-06-12 2017-01-05 キヤノン株式会社 化合物又はその薬学的に受容可能な塩、及び、前記化合物又はその薬学的に受容可能な塩を有する光音響イメージング用造影剤。
JP6789636B2 (ja) 2015-09-30 2020-11-25 キヤノン株式会社 重合体、前記重合体を有する光音響イメージング用造影剤
WO2017057653A1 (en) 2015-09-30 2017-04-06 Canon Kabushiki Kaisha Conjugate of polysarcosine and nir contrast agent for photoacoustic imaging
CN105688230B (zh) * 2016-02-02 2018-12-11 史春梦 七甲川吲哚花菁染料-聚乙二醇-叶酸复合物及制备方法和应用
CN109054013A (zh) * 2018-08-22 2018-12-21 东北大学 一种经修饰的吲哚菁绿及其制备方法
CN109738387A (zh) * 2018-12-29 2019-05-10 佛山科学技术学院 一种基于吲哚箐绿的光学相干层析成像方法和装置
WO2025197935A1 (ja) * 2024-03-19 2025-09-25 国立大学法人 東京大学 薬物－ポリマー複合体、医薬組成物、および薬物送達用ポリマー

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622685A (en) 1990-05-30 1997-04-22 Deutches Krebsforchunszentrum Stiftung Des Offentlichen Rechts Polyether-substituted porphyrin anti-tumor agents
DE4445065A1 (de) 1994-12-07 1996-06-13 Diagnostikforschung Inst Verfahren zur In-vivo-Diagnostik mittels NIR-Strahlung
ATE257014T1 (de) 1997-04-29 2004-01-15 Amersham Health As Lichtbilderzeugungskontrastmitteln
GB2337523A (en) * 1998-04-29 1999-11-24 Nycomed Imaging As Light imaging contrast agents
US20100143258A1 (en) * 2008-12-05 2010-06-10 General Electric Company Tumor margin imaging agents

Also Published As

Publication number Publication date
US20120114563A1 (en) 2012-05-10
AU2010224789A1 (en) 2011-10-06
CA2755770A1 (en) 2010-09-23
RU2011138096A (ru) 2013-04-27
BRPI1009346A2 (pt) 2017-05-30
WO2010106169A1 (en) 2010-09-23
CN102438659A (zh) 2012-05-02
KR20110138246A (ko) 2011-12-26
JP2012520856A (ja) 2012-09-10
EP2413976A1 (en) 2012-02-08

Similar Documents

Publication Publication Date Title
MX2011009808A (es) Agentes de elaboracion de imagen optica.
WO2009140423A3 (en) Targeted polymer bioconjugates
GB0718957D0 (en) Optical imaging agents
CY1125550T1 (el) Ορισμενες τριαζολοπυραζινες, συνθεσεις αυτων και μεθοδοι για τη χρηση αυτων
CY1125300T1 (el) Φαρμακευτικες συνθεσεις που περιεχουν οξειδιο-υδροξειδιο του σιδηρου
WO2009112488A3 (en) Polyether polyol dendron conjugates with effector molecules for biological targeting
MX368966B (es) Conjugados de proteina-polimero-farmaco.
NZ588884A (en) Cross-linkers and their uses
JO3026B1 (ar) مستضادات ببتيد شبيه الجلوكاجون - 2
CY1117312T1 (el) Θεραπευτικη αγωγη συνουκλεϊνοπαθειων
MX2011012599A (es) Compuestos polimericos de agentes inmunomoduladores.
WO2017112825A3 (en) Polymer conjugates having reduced antigenicity and methods of using the same
WO2012116272A3 (en) Polymer conjugated protein micelles
BRPI0923047B8 (pt) métodos para preparação de conjugados de proteínas- oligossacarídeos
EA201200617A1 (ru) Полимеры на основе циклодекстрина для доставки лекарственных средств
WO2011062965A8 (en) Targeting monomers and polymers having targeting blocks
EA032867B9 (ru) Оптимизированная с помощью эндосомолитических средств система доставки in vivo конъюгатов нуклеиновой кислоты
WO2010037069A3 (en) Dithienopyrrole dyes for imaging and therapy
MX2009004435A (es) Tinturas dispersas, su preparacion y su uso.
WO2011053901A3 (en) Magnetic nanostructures as theranostic agents
EA201170533A1 (ru) Высокодиспергируемый диоксид кремния для резин и способ его получения
ECSP12012314A (es) Factor viii conjugado para coagulación de la sangre
MX2012010448A (es) Conjugados de carbohidrato-poli aminoacido-farmaco.
WO2013040251A3 (en) Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease
WO2010072752A3 (en) Fluorescent probes having a polymeric backbone

Legal Events

Date Code Title Description
FA Abandonment or withdrawal